Stay updated on Nivolumab in AML Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Prevention Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Locations section updated with new site listings across multiple states and Ontario. Page revision updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T13:50:23.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The update timestamp label changes from 'Last Update Posted' to 'Last Update Posted (Estimated)'. This is a minor textual adjustment to the update information on the study details page.
    Difference
    0.0%
    Check dated 2025-12-16T03:28:32.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    New 'Last Update Posted' dates were added (2025-12-08 and 2025-11-22), and the previously listed 'Last Update Posted (Estimated)' entries (2025-11-06 and 2025-11-19) were removed.
    Difference
    0.1%
    Check dated 2025-12-09T00:54:16.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The Publications section now states that entries are automatically filled from PubMed, and a new revision tag (v3.3.2, 2025-11-19) replaces the previous note and revision (v3.2.0, 2025-10-24).
    Difference
    0.2%
    Check dated 2025-11-24T19:06:17.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Two new timestamp fields were added: Results First Posted (Estimated) and Last Update Posted (Estimated); these are metadata updates and do not alter substantive study content, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T18:06:09.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added a Results section detailing progression-free survival (PFS), overall survival (OS), non-relapse mortality (NRM), and adverse events, with Results First Posted dates and links to the Informed Consent Form and the Study Protocol / Statistical Analysis Plan.
    Difference
    1%
    Check dated 2025-11-10T16:24:30.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Prevention Clinical Trial page.